en
/
fr
Investors
Entrepreneurs
Joining our team
About
About Seventure
Our Investment Strategy
Our Portfolio
Our Team
Regulatory policies
ESG Commitments
Our Expertise
Products
Our FCPI
Our Institutional Funds
News
Contact us
Investors
Entrepreneurs
Joining our team
en
/
fr
Search
Search
Ok
4__104270789
Post navigation
Published in
LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University